Ternary Therapeutics

About Ternary Therapeutics

TernaryTx is a London-based biotech startup focused on revolutionising molecular glue discovery through computational design. By combining state-of-the-art machine learning, molecular dynamics simulations, and AI-augmented drug discovery expertise, the company designs and identifies molecular glue degraders and activators to target challenging protein interactions. Their pipeline and technologies—including virtual discovery platforms and models for hot-spot prediction—aim to enable rapid, rationale design of ternary complexes across various indications. The team operates from the WorkWell in London and collaborates with facilities such as Stevenage Bioscience Catalyst to advance drug discovery in the UK.